# US 2025/0145992 A1 · Oligonucleotides with ethylene glycol modification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0145992 A1
- Document ID: US20250145992A1
- Status: Published application
- Kind: A1
- Application number: 18/918,355
- Filed: 2024-10-17
- Published: 2025-05-08
- Earliest claimed: 2023-10-18
- Assignees: University of Massachusetts
- Applicants: University of Massachusetts
- Inventors: Anastasia Khvorova; Daniel O'Reilly; Vignesh Narayan Hariharan; Raymond Furgal; Katherine Gross
- Web page: https://patentgrep.com/patent/US20250145992A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2310/315: Phosphorothioates
- C12N 2310/321: 2'-O-R Modification
- C12N 2310/322: 2'-R Modification
- C12N 2310/344: Position-specific modifications, e.g. on every purine, at the 3'-end
- C12N 2310/3515: Lipophilic moiety, e.g. cholesterol
- C12N 2310/3521: Methyl
- C12N 2310/3533: Halogen
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The disclosure relates to compositions, systems, and methods comprising ethylene glycol chemical modifications on oligonucleotides to modulate silencing activity and improve stability.

## Claims

### Claim 1

An RNA molecule comprising a 5′ end and a 3′ end, wherein the RNA molecule comprises at least one ethylene glycol modification to one or both of the 5′ end and the 3′ end, wherein the at least one ethylene glycol modification comprises 1-20 ethylene glycol units.

### Claim 2 (depends on 1)

The RNA molecule of claim 1, wherein the at least one ethylene glycol modification comprises 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 ethylene glycol units.

### Claim 3 (depends on 1)

The RNA molecule of claim 1, wherein the RNA molecule comprises 2-5 ethylene glycol modifications.

### Claim at position 4

4-7. (canceled)

### Claim 8 (depends on 1)

The RNA molecule of claim 1, wherein the at least one ethylene glycol modification is positioned between two adjacent nucleotides.

### Claim 9 (depends on 1)

The RNA molecule of claim 1, wherein:
the at least one ethylene glycol modification does not replace a nucleotide at a position within the RNA molecule relative to an RNA molecule that does not contain the at least one ethylene glycol modification at the same position within the RNA molecule; or
the at least one ethylene glycol modification replaces a nucleotide at a position within the RNA molecule relative to an RNA molecule that does not contain the at least one ethylene glycol modification at the same position within the RNA molecule.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The RNA molecule of claim 1, wherein the RNA molecule further comprises at least one alkyl modification to one or both of the 5′ end and the 3′ end.

### Claim 12 (depends on 11)

The RNA molecule of claim 11, wherein the at least one alkyl modification comprises a C1-C10 alkyl.

### Claim 13

(canceled)

### Claim 14 (depends on 11)

The RNA molecule of claim 11, wherein the RNA molecule comprises 2-5 alkyl modifications.

### Claim at position 12

15-18. (canceled)

### Claim 19 (depends on 11)

The RNA molecule of claim 11, wherein the at least one alkyl modification is positioned between two adjacent nucleotides.

### Claim 20 (depends on 11)

The RNA molecule of claim 11, wherein:
the at least one alkyl modification does not replace a nucleotide at a position within the RNA molecule relative to an RNA molecule that does not contain the at least one alkyl modification at the same position within the RNA molecule; or
the at least one alkyl modification replaces a nucleotide at a position within the RNA molecule relative to an RNA molecule that does not contain the at least one alkyl modification at the same position within the RNA molecule.

### Claim 21

(canceled)

### Claim 22 (depends on 1)

The RNA molecule of claim 1, wherein the RNA molecule comprises a single stranded RNA (ssRNA) or a double stranded RNA (dsRNA).

### Claim at position 17

23-44. (canceled)

### Claim 45 (depends on 22)

The RNA molecule of claim 22, wherein the RNA molecule comprises the dsRNA comprising an antisense strand and a sense strand, each strand with a 5′ end and a 3′ end, and wherein the antisense strand is between 15 and 25 nucleotides in length.

### Claim 46

(canceled)

### Claim 47 (depends on 22)

The RNA molecule of claim 22, wherein the RNA molecule comprises the dsRNA comprising an antisense strand and a sense strand, each strand with a 5′ end and a 3′ end, and wherein the sense strand is between 15 and 25 nucleotides in length.

### Claim at position 21

48-50. (canceled)

### Claim 51 (depends on 11)

The RNA molecule of claim 11, further comprising at least one chemically-modified nucleotide that is different from the at least one alkyl modification or the at least one ethylene glycol modification.

### Claim 52 (depends on 51)

The RNA molecule of claim 51, wherein the at least one chemically-modified nucleotide comprises a 2′-O-methyl modified nucleotide, a 2′-deoxy-2′-fluoro modified nucleotide, a 2′-deoxy-modified nucleotide, a locked nucleotide, an abasic nucleotide, a 2′-amino-modified nucleotide, a 2′-alkyl-modified nucleotide, a morpholino nucleotide, a phosphoramidate, a non-natural base comprising nucleotide, or a mixture thereof.

### Claim 53 (depends on 22)

The RNA molecule of claim 22, wherein the RNA molecule comprises the dsRNA comprising at least one modified internucleotide linkage.

### Claim 54 (depends on 53)

The RNA molecule of claim 53, wherein the at least one modified internucleotide linkage comprises a phosphorothioate internucleotide linkage.

### Claim at position 26

55-56. (canceled)

### Claim 57 (depends on 22)

The RNA molecule of claim 22, wherein the dsRNA comprises a blunt end and/or at least one single stranded nucleotide overhang.

### Claim at position 28

58-64. (canceled)

### Claim 65 (depends on 57)

The RNA molecule of claim 57, wherein the dsRNA comprises the at least one single stranded nucleotide overhang comprising 2, 3, 4, or 5 alkyl modifications.

### Claim 66 (depends on 1)

The RNA molecule of claim 1, comprising an antisense strand with a chemical modification pattern of any one of the chemical modification patterns provided in Tables 2-6.

### Claim 67

(canceled)

### Claim 68

A double stranded RNA (dsRNA), comprising an antisense strand and a sense strand, each strand with a 5′ end and a 3′ end, wherein the antisense strand comprises at least one ethylene glycol modification to one or both of the 5′ end and the 3′ end, wherein the at least one ethylene glycol modification comprises 1-20 ethylene glycol units.

### Claim at position 33

69-92. (canceled)

### Claim 93

A double stranded RNA (dsRNA), comprising an antisense strand and a sense strand, each strand with a 5′ end and a 3′ end, and at least one single stranded nucleotide overhang of 2-5 nucleotides, wherein the at least one single stranded nucleotide overhang comprises at least one ethylene glycol modification.

### Claim at position 35

94-96. (canceled)

### Claim 97

A double stranded RNA (dsRNA), comprising an antisense strand and a sense strand, each strand with a 5′ end and a 3′ end, wherein;
the antisense strand comprises a chemical modification pattern of any one of the chemical modification patterns provided in Tables 2-6; or
the sense strand comprises a chemical modification pattern of any one of the chemical modification patterns provided in Tables 2-3.

### Claim 98

(canceled)

### Claim 99 (depends on 1)

A method for reducing expression of a target mRNA in a subject, comprising administering to the subject the RNA molecule of claim 1.

### Claim at position 39

100-101. (canceled)
